A61K 9/485
Inorganic compounds
Official title: {Inorganic compounds}
A61K9/485 (Inorganic compounds) appears on 522 US grants and 1,087 published applications in this corpus.
Search patents in A61K- Granted patents
- 522
- Published applications
- 1,087
- Assignees
- 481
- Inventors
- 1,902
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 5 |
| 2002 | 5 | 4 |
| 2003 | 5 | 14 |
| 2004 | 3 | 12 |
| 2005 | 5 | 8 |
| 2006 | 2 | 14 |
| 2007 | 1 | 15 |
| 2008 | 1 | 11 |
| 2009 | 2 | 19 |
| 2010 | 6 | 11 |
| 2011 | 8 | 11 |
| 2012 | 5 | 17 |
| 2013 | 11 | 46 |
| 2014 | 12 | 30 |
| 2015 | 22 | 65 |
| 2016 | 36 | 81 |
| 2017 | 27 | 72 |
| 2018 | 33 | 60 |
| 2019 | 36 | 79 |
| 2020 | 45 | 65 |
| 2021 | 38 | 76 |
| 2022 | 39 | 76 |
| 2023 | 32 | 77 |
| 2024 | 45 | 102 |
| 2025 | 39 | 73 |
| 2026 | 31 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- API stability in softgels29 Sep 2026US 12,746,206 B2R.P. Scherer Technologies, LLC
- Orally administered solid dosage form drug4 Aug 2026US 12,697,306 B2Ascentawits Pharmaceuticals, Ltd.
- Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative28 Jul 2026US 12,691,090 B2Xwpharma Ltd.
- Compositions and methods for treating diabetes28 Jul 2026US 12,691,163 B2Poviva Corp.
- Pralsetinib pharmaceutical compositions28 Jul 2026US 12,692,251 B2Rigel Pharmaceuticals, Inc.
- Composition for oral use with hmg-coa reductase enzyme inhibiting activity1 Oct 2026US 2026/0294995 A1Difass International S.P.A.
- Crystalline adipic acid salt form of a ccr6 antagonist17 Sep 2026US 2026/0272902 A1Idorsia Pharmaceuticals Ltd
- Pentamidine analogue polymorphs, formulations, and methods thereof17 Sep 2026US 2026/0274798 A1Auransa Inc.
- Pharmaceutical compositions with improved dissolution20 Aug 2026US 2026/0240784 A1APPLIED Materials.Inc.
- Crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6- yl]phenyl]-4-[[3(r)-[(l-oxo-2-propen-l-yl)amino]-l-piperidinyl]methyl]-2-pyridinecarboxamide as a covalent inhibitor of menin-mll interaction13 Aug 2026US 2026/0232681 A1Biomea Fusion, Inc.
Most cited
By later US patents
- Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents638US 6,383,471 B1Lipocine Inc. · 2002
- Pharmaceutical formulation containing gelling agent198US 8,337,888 B2Purdue Pharma L. P. · 2012
- Solvent system enhancing the solubility of pharmaceuticals for encapsulation109US 5,071,643 AR. P. Scherer Corporation · 1991
- Pharmaceutical composition containing gelling agent96US 8,389,007 B2Purdue Pharma L. P. · 2013
- Pharmaceutical formulation containing gelling agent87US 8,609,683 B2Purdue Pharma L. P. · 2013